Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

ACR President Dr. Joan Von Feldt Reflects on Her Year in Office, Advancing Rheumatology!

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  November 16, 2016

This has been a year of tremendous growth, change and achievement for the ACR, and I have been fortunate to lead the ACR in these endeavors. The ACR and ARHP, including the ACR Executive Committee, the ACR Board of Directors, standing and special committee chairs and hundreds of dedicated volunteers, have contributed to this growth…

Filed under:President's Perspective Tagged with:American College of Rheumatology (ACR)Dr. Joan Von Feldtofficepresidentrheumatology

Lateral Hip Pain: Could It Be Gluteal Tendinopathy?

Lara C. Pullen, PhD  |  November 14, 2016

Researchers recently found that physical tests that involve an active muscle contraction were most useful in identifying gluteal tendinopathy in patients with lateral hip pain. However, patients who were not palpably tender over the greater trochanter were unlikely to have GT detected during an MRI…

Filed under:ConditionsSoft Tissue Pain Tagged with:gluteal tendinopathyhiphip painMagnetic resonance imaging (MRI)MRITendinopathy

Second Biosimilar Equivalent to Adalimumab

Michele B. Kaufman, PharmD, BCGP  |  November 9, 2016

A recent study established the equivalency of BI 695501, a biosimilar, to its reference product, adalimumab, for treating patients with rheumatoid arthritis…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBI 695501BiosimilarsFDAFood and Drug AdministrationLabeling Changessafety warningtestosterone

Treating the Athlete: New Thoughts on How to Prevent & Treat Arthritis in Athletes & Raise Their Awareness

Karen Appold  |  November 4, 2016

All athletes—amateur and professional—should understand their risks for developing injury-related arthritis. Rheumatologists and other physicians at the Hospital for Special Surgery in New York take a rapid approach to treating athletes, often considering intense physical therapy, innovative treatments and surgery much sooner than for the average patient—all to keep joints healthy and enable athletes to play for as long as possible…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Exercise/physical therapyinjuryphysical fitnessPhysical Therapysecukinumab

Designate a Data Expert for Your Practice

Richard Quinn  |  October 21, 2016

With Medicare and insurers now incentivizing physicians for collecting and reporting data, rheumatologists need at least a minimum understanding of the gigabytes of information flowing through their practices. Actually, every medical practice should have at least one person with some informatics expertise, according to computer-programmer-turned-rheumatologist Jeffrey Curtis, MD, MS, MPH. “Physicians need to be more…

Filed under:Information TechnologyTechnologyTechnology Tagged with:data managementHealth Information Technologypatient dataRISERISE registryTechnology

Choose the Right EHR the 1st Time

Karen Appold  |  October 20, 2016

With so many electronic health record (EHR) systems on the market, it can be difficult to decide which one to choose. You may want to ask your peers for recommendations, visit practices that are using a system you’re contemplating and consider advice in trade journals. Jeffrey G. Lawson, MD, physician, Piedmont Arthritis Clinic, Greenville, S.C.,…

Filed under:EMRsPractice SupportProfessional Topics Tagged with:EHRElectronic health records

The Impact of U.S. Supreme Court Decisions on Medical Affairs, Healthcare Policy

Simon M. Helfgott, MD  |  October 11, 2016

As America’s capital, Washington, D.C., maintains an outsized influence in our daily lives. Despite having a meager sliver of the New York City population, the daily political transactions that transpire in the District of Columbia impact our lives. The comings and goings in the corridors of Congress are likely to have a greater impact on us…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:Affordable Care Act (ACA)BRCADNAgeneHealth carejudiciarylawsLegislationmedicalSupreme CourtVermont

Rheumatology Drug Updates: Abaloparatide Promising for Osteoporosis, Plus Secukinumab for Ankylosing Spondylitis

Michele B. Kaufman, PharmD, BCGP  |  October 10, 2016

Abaloparatide for Osteoporosis Abaloparatide is completing Phase III clinical trials for the potential treatment of postmenopausal osteoporosis in women who are at an increased risk of fracture.1 Abaloparatide is a synthetic peptide that engages the parathyroid hormone receptor and has favorable bone building activity. Abaloparatide has completed Phase 3 development for use as a daily…

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:abaloparatideAnkylosing SpondylitisApprovalsclinical trialsdrugFDAOsteoporosisRheumatic DiseaserheumatologySafetysecukinumab

As Role of Kinase Inhibitors in Rheumatic Disease Treatment Expands, Experts Review Therapy’s Failures, Successes

Thomas R. Collins  |  October 10, 2016

LONDON—Kinase inhibitors’ profile in the world of rheumatic disease therapy is growing, and they are probably going to play an even larger and more central role as time goes on, experts said at the Annual Congress of the European League Against Rheumatism (EULAR) 2016. But Gary S. Firestein, MD, director of the Clinical and Translational…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:EULARfailurejanus kinase inhibitorkinase inhibitorResearchRheumatic DiseasesuccesstargettherapyTNF inhibitorTreatment

Racial Bias Found in Pain Assessment, Management, Treatment Recommendations by Clinicians

Mary Beth Nierengarten  |  October 10, 2016

In the world of evidence-based medicine, basing diagnosis and treatment decisions on belief instead of data seems anachronistic. And yet … clinicians are human, and humans live in culture, and culture is formed by beliefs, and beliefs (consciously or unconsciously) drive perception and, often, action. So a new study shining a light on racial bias…

Filed under:Practice SupportQuality Assurance/ImprovementResearch Rheum Tagged with:biasclinicianDiagnosisPainpatient careracialResearchrheumatologist

  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences